Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sun exposure and melanoma prognostic factors.
Gandini S, Montella M, Ayala F, Benedetto L, Rossi CR, Vecchiato A, Corradin MT, DE Giorgi V, Queirolo P, Zannetti G, Giudice G, Borroni G, Forcignanò R, Peris K, Tosti G, Testori A, Trevisan G, Spagnolo F, Ascierto PA; CLINICAL NATIONAL MELANOMA REGISTRY GROUP. Gandini S, et al. Among authors: peris k. Oncol Lett. 2016 Apr;11(4):2706-2714. doi: 10.3892/ol.2016.4292. Epub 2016 Mar 1. Oncol Lett. 2016. PMID: 27073541 Free PMC article.
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.
Seidenari S, Benati E, Ponti G, Borsari S, Ferrari C, Albertini G, Altomare G, Arcangeli F, Aste N, Bernengo MG, Bongiorno MR, Borroni G, Calvieri S, Chimenti S, Cusano F, Fracchiolla C, Gaddoni G, Girolomoni G, Guarneri B, Lanzoni A, Lombardi M, Lotti T, Mariotti A, Marsili F, Micali G, Parodi A, Peris K, Peserico A, Quaglino P, Santini M, Schiavon S, Tonino C, Trevisan G, Tribuzi P, Valentini P, Vena GA, Virgili A. Seidenari S, et al. Among authors: peris k. Eur J Cancer Prev. 2012 Jan;21(1):89-95. doi: 10.1097/CEJ.0b013e3283498e14. Eur J Cancer Prev. 2012. PMID: 22001916 Free article.
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients.
Fava P, Astrua C, Chiarugi A, Crocetti E, Pimpinelli N, Fargnoli MC, Maurichi A, Rubegni P, Manganoni AM, Bottoni U, Catricalà C, Cavicchini S, Santinami M, Alaibac M, Annetta A, Borghi A, Calzavara Pinton P, Capizzi R, Clerico R, Colombo E, Corradin MT, De Simone P, Fantini F, Ferreli C, Filosa G, Girgenti V, Giulioni E, Guarneri C, Lamberti A, Lisi P, Nardini P, Papini M, Peris K, Pizzichetta MA, Salvini C, Savoia P, Strippoli D, Tolomio E, Tomassini MA, Vena GA, Zichichi L, Patrizi A, Argenziano G, Simonacci M, Quaglino P. Fava P, et al. Among authors: peris k. Dermatology. 2015;230(3):256-62. doi: 10.1159/000368775. Epub 2015 Jan 31. Dermatology. 2015. PMID: 25659983 Free article.
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Bossi P. Baggi A, et al. Among authors: peris k. Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536948
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258].
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Zamparini M, Bossi P. Baggi A, et al. Among authors: peris k. Eur J Cancer. 2022 May;166:309-310. doi: 10.1016/j.ejca.2022.02.027. Epub 2022 Mar 24. Eur J Cancer. 2022. PMID: 35341663 Free article. No abstract available.
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment.
Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, Leiter U, Stadler R, Sunderkötter C, Tüting T, Utikal J, Wollina U, Zimmer L, Zouboulis CC, Ascierto PA, Eggermont AMM, Grob JJ, Hauschild A, Sekulovic LK, Long GV, Luke JJ, Michielin O, Peris K, Schadendorf D, Kirkwood JM, Lorigan PC; Central Malignant Melanoma Registry (CMMR). Garbe C, et al. Among authors: peris k. J Clin Oncol. 2022 Nov 10;40(32):3741-3749. doi: 10.1200/JCO.22.00202. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709414 Free PMC article.
598 results